Regulation And Legal
Granules India's US Facility Completes FDA Audit with 4 Observations
Granules India's US subsidiary, Granules Pharmaceuticals, Inc., has completed a routine cGMP audit by the US FDA at its Chantilly facility.
The audit, conducted from March 30 to April 3, 2026, resulte
